Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OTUD7B | Q6GQQ9 | 9/20 | 0.76 |
| ▸ | USP30 | Q70CQ3 | 9/20 | 0.71 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.59 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17632124 | 1.00 | OTUD7B (0.76) | OTUD7BUSP30UCHL1MKNK1 | |
| SCHEMBL19049845 | 0.87 | OTUD7B (1.00) | OTUD7BUSP30UCHL1 | |
| SCHEMBL19031337 | 0.87 | OTUD7B (1.00) | OTUD7BUSP30UCHL1 | |
| SCHEMBL17643981 | 0.87 | OTUD7B (0.75) | OTUD7BUSP30UCHL1 | |
| SCHEMBL19281681 | 0.86 | OTUD7B (0.71) | OTUD7BUSP30UCHL1MKNK1 | |
| SCHEMBL17632243 | 0.86 | OTUD7B (0.68) | OTUD7BUSP30UCHL1MKNK1 | |
| SCHEMBL25052373 | 0.86 | OTUD7B (0.68) | OTUD7BUSP30UCHL1MKNK1 | |
| SCHEMBL17643723 | 0.83 | OTUD7B (0.54) | OTUD7BUSP30UCHL1MKNK1 | |
| SCHEMBL23198240 | 0.83 | USP30 (1.00) | OTUD7BUSP30UCHL1 | |
| SCHEMBL23403452 | 0.82 | OTUD7B (0.54) | OTUD7BUSP30UCHL1MKNK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230052191-A1 | NOVEL COMPOUNDS | MISSION THERAPEUTICS LTD (GB) | 2023-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230052191-A1 | NOVEL COMPOUNDS | UCHL1, UCHL3, UCHL5 | OTUD7B 64/4885USP30 19/4885UCHL1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.